Trials / Completed
CompletedNCT01387802
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis (Complete - AS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 722 (actual)
- Sponsor
- AbbVie (prior sponsor, Abbott) · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The current study will assess the real - life effectiveness of adalimumab in the management of Ankylosing Spondylitis (AS) with emphasis on the prevention and management of extra-articular manifestations.
Conditions
Timeline
- Start date
- 2011-06-29
- Primary completion
- 2019-12-16
- Completion
- 2019-12-16
- First posted
- 2011-07-06
- Last updated
- 2020-12-09
Locations
56 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01387802. Inclusion in this directory is not an endorsement.